Neil Bhowmick 2 protocols

Veronica Placencio-Hickok Hematology/Oncology, Cedars-Sinai Medical Center, USA, USA,
1 protocol

Manabu Kato
  • Mie University Hospital, Nephro-Urologic Surgery and Andrology, Japan, Japan,
  • 1 Author merit

Education

PhD, Mie University, Japan, 2015

Current position

M.D., PhD, Urology, Mie University, Japan

Publications

  1. Pirfenidone, an Anti-Fibrotic Drug, Suppresses the Growth of Human Prostate Cancer Cells by Inducing G₁ Cell Cycle Arrest. Ishii K, Sasaki T, Iguchi K, Kato M, Kanda H, Hirokawa Y, Arima K, Watanabe M, Sugimura Y. J Clin Med. 2019 Jan 4;8(1). pii: E44. doi: 10.3390/jcm8010044. 
  2. Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner. Kato M, Placencio-Hickok VR, Madhav A, Haldar S, Tripathi M, Billet S, Mishra R, Smith B, Rohena-Rivera K, Agarwal P, Duong F, Angara B, Hickok D, Liu Z, Bhowmick NA. Oncogene. 2019 Jan;38(5):716-730. doi: 10.1038/s41388-018-0461-3. Epub 2018 Sep 3. 
  3. Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme. Miki M, Ishii K, Sasaki T, Kato M, Kajiwara S, Kanda H, Arima K, Hirokawa Y, Watanabe M, Sugimura Y. Urol Oncol. 2018 Oct;36(10):472.e1-472.e9. doi: 10.1016/j.urolonc.2018.07.008. Epub 2018 Aug 20. 
  4. Interleukin-6 induces VEGF secretion from prostate cancer cells in a manner independent of androgen receptor activation. Ishii K, Sasaki T, Iguchi K, Kajiwara S, Kato M, Kanda H, Hirokawa Y, Arima K, Mizokami A, Sugimura Y. Prostate. 2018 Aug;78(11):849-856. doi: 10.1002/pros.23643. Epub 2018 Apr 29. 
  5. Additive naftopidil treatment synergizes docetaxel-induced apoptosis in human prostate cancer cells. Ishii K, Matsuoka I, Kajiwara S, Sasaki T, Miki M, Kato M, Kanda H, Arima K, Shiraishi T, Sugimura Y. J Cancer Res Clin Oncol. 2018 Jan;144(1):89-98. doi: 10.1007/s00432-017-2536-x. Epub 2017 Nov 2. 
  6. Combination treatment with naftopidil increases the efficacy of radiotherapy in PC-3 human prostate cancer cells. Iwamoto Y, Ishii K, Kanda H, Kato M, Miki M, Kajiwara S, Arima K, Shiraishi T, Sugimura Y. J Cancer Res Clin Oncol. 2017 Jun;143(6):933-939. doi: 10.1007/s00432-017-2367-9. Epub 2017 Feb 27. 
  7. Successful Preservation of the Bladder in a Case of Inflammatory Myofibroblastic Tumor with the Diagnostic Efficacy of ALK/p80 Immunohistochemistry and FISH Analysis: Case Report and Review of the Literature. Kato M, Masui S, Kanda H, Arima K, Shiraishi T, Sugimura Y. Urol Case Rep. 2017 Jan 5;11:19-21. doi: 10.1016/j.eucr.2016.11.018. eCollection 2017 Feb. 
  8. Fibroblasts prolong serum prostate-specific antigen decline after androgen deprivation therapy in prostate cancer. Sasaki T, Ishii K, Iwamoto Y, Kato M, Miki M, Kanda H, Arima K, Shiraishi T, Sugimura Y. Lab Invest. 2016 Mar;96(3):338-49. doi: 10.1038/labinvest.2015.136. Epub 2015 Dec 7. 
  9. Activation of FGF2-FGFR signaling in the castrated mouse prostate stimulates the proliferation of basal epithelial cells. Kato M, Ishii K, Iwamoto Y, Sasaki T, Kanda H, Yamada Y, Arima K, Shiraishi T, Sugimura Y. Biol Reprod. 2013 Oct 4;89(4):81. doi: 10.1095/biolreprod.112.107516. Print 2013 Oct.
1 Protocol published
3D Co-culture System of Mouse Prostatic Wild-type Fibroblasts with Human Prostate Cancer Epithelial Cells
Authors:  Veronica R. Placencio-Hickok, Manabu Kato and Neil A. Bhowmick, date: 05/05/2019, view: 1001, Q&A: 0
Heterogeneous prostatic carcinoma-associated fibroblasts (CAF) contribute to tumor progression. This was established using transgenic mouse models. Paracrine interactions between fibroblasts and epithelial cells were further interrogated using ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.